Comparative effects of aspirin with ACE inhibitor or angiotensin receptor blocker on myocardial infarction and vascular function

Objectives We previously showed that an angiotensin-converting enzyme inhibitor (captopril) or an angiotensin receptor blocker (losartan) reduced infarct size and improved endothelial function in a rat model of ischaemia-reperfusion. The present study was undertaken to see if aspirin (ASA) antagonised the beneficial effects of captopril or losartan. Methods One hundred and fourteen Sprague-Dawley rats were randomised into six groups; Control, ASA, captopril, losartan, ASA+captopril, and ASA+losartan. ASA, captopril or losartan were given at a concentration of 40 mg/kg/day in drinking water. After six weeks of pre-treatment, the rats were subjected to 17 minutes of left anterior descending coronary artery occlusion and 120 minutes of reperfusion, with haemodynamic and ECG monitoring. During the reperfusion period, the effective refractory period (ERP), ventricular fibrillation threshold (VFT) and bleeding time (BT) were measured. In fresh aortic rings precontracted with phenylephrine, endothelium-dependent and -independent relaxations were assessed using acetylcholine and nitroglycerin. Results Haemodynamic changes were not different between the groups. Serum ASA concentrations were 0.5, 1.1 and 0.6 mg/dl in the ASA, ASA+captopril and ASA+losartan groups, respectively, and BT was prolonged (p<0.01). ASA alone reduced endothelium-dependent relaxation (-29±8 vs. -69±11%, p<0.01), but did not change endothelium-independent relaxation. ASA did not affect endothelial relaxation induced by acetylcholine in the presence of either captopril or losartan. Angiotensin I and ERP were elevated by captopril and losartan. Angiotensin II and VFT were elevated by losartan. ASA with captopril, captopril and losartan equally reduced infarct size, compared with control (39±3, 39±4 and 39±5 vs. 53±3%, all p<0.05). Conclusions Captopril and losartan had similar cardiovascular protective effects in a rat model of ischaemia-reperfusion. Aspirin did not attenuate the cardiovascular protective effects of captopril or losartan.

[1]  M. Pfeffer,et al.  Effects of long-term treatment with angiotensin-converting enzyme inhibitors in the presence or absence of aspirin: A systematic review ☆ , 2003 .

[2]  L. Lipsitz,et al.  Does Aspirin Attenuate the Effect of Angiotensin‐Converting Enzyme Inhibitors on Health Outcomes of Very Old Patients with Heart Failure? , 2002, Journal of the American Geriatrics Society.

[3]  Ali Ahmed,et al.  Interaction Between Aspirin and Angiotensin‐Converting Enzyme Inhibitors: Should They Be Used Together in Older Adults with Heart Failure? , 2002, Journal of the American Geriatrics Society.

[4]  A. Tenenbaum,et al.  Clinical evidence of dose-dependent interaction between aspirin and angiotensin-converting enzyme inhibitors , 2002, Journal of Human Hypertension.

[5]  J. McMurray,et al.  Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor. , 2002, British journal of clinical pharmacology.

[6]  T. Ohe,et al.  Effects of low‐dose aspirin on endothelial function in hypertensive patients , 2001, Clinical cardiology.

[7]  D. Hall,et al.  Controversies in heart failure. Are beneficial effects of angiotensin-converting enzyme inhibitors attenuated by aspirin in patients with heart failure? , 2001, Cardiology clinics.

[8]  J. Cleland,et al.  Does aspirin attenuate the effect of angiotensin-converting enzyme inhibitors in hypertension or heart failure? , 2001, Current opinion in nephrology and hypertension.

[9]  S. Glantz,et al.  Comparative Effects of ACE Inhibitors and an Angiotensin Receptor Blocker on Atherosclerosis and Vascular Function , 2001, Journal of cardiovascular pharmacology and therapeutics.

[10]  W. Parmley,et al.  Effects of different durations of pretreatment with losartan on myocardial infarct size, endothelial function, and vascular endothelial growth factor , 2001, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[11]  H. Arnesen,et al.  Aspirin does not influence the effect of angiotensin‐converting enzyme inhibition on left ventricular ejection fraction 3 months after acute myocardial infarction , 2001, European journal of heart failure.

[12]  H. Krumholz,et al.  Aspirin and angiotensin-converting enzyme inhibitors among elderly survivors of hospitalization for an acute myocardial infarction. , 2001, Archives of internal medicine.

[13]  K. Harjai,et al.  Effect of combined aspirin and angiotensin-converting enzyme inhibitor therapy versus angiotensin-converting enzyme inhibitor therapy alone on readmission rates in heart failure. , 2001, The American journal of cardiology.

[14]  J. Mourad,et al.  Interaction between angiotensin-converting enzyme inhibitors and aspirin: a review , 2000, European Journal of Clinical Pharmacology.

[15]  E. Topol,et al.  Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease. , 2000, The American journal of medicine.

[16]  B. Massie,et al.  Interaction between aspirin and angiotensin-converting enzyme inhibitors: real or imagined. , 2000, The American journal of medicine.

[17]  A. Tenenbaum,et al.  Intermediate but not low doses of aspirin can suppress angiotensin-converting enzyme inhibitor-induced cough. , 2000, American journal of hypertension.

[18]  S. Spinler,et al.  Update on the Interaction Between Aspirin and Angiotensin‐Converting Enzyme Inhibitors , 2000, Pharmacotherapy.

[19]  R. Collins,et al.  Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collab , 2000, Journal of the American College of Cardiology.

[20]  D. Hall.  The aspirin-angiotensin-converting enzyme inhibitor tradeoff: to halve and halve not. , 2000, Journal of the American College of Cardiology.

[21]  W. Parmley,et al.  Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion. , 2000, Journal of the American College of Cardiology.

[22]  L. Tavazzi,et al.  Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial. , 1998, Heart disease.

[23]  R. Townsend,et al.  Effect of aspirin on blood pressure in hypertensive patients taking enalapril or losartan. , 1999, American journal of hypertension.

[24]  M. Abdelnoor,et al.  Infarct Size Is Reduced and the Frequency of Non-Q-Wave Myocardial Infarctions Is Increased in Patients Using Aspirin at the Onset of Symptoms , 1999, Cardiology.

[25]  B. Massie,et al.  The interaction of ACE inhibitors and aspirin in heart failure: torn between two lovers. , 1999, American heart journal.

[26]  R. Goldberg,et al.  Recent aspirin use is associated with smaller myocardial infarct size and lower likelihood of Q-wave infarction. , 1999, American heart journal.

[27]  R. García,et al.  Effect of losartan on human platelet activation. , 1999, Journal of hypertension.

[28]  S. Glantz,et al.  In-utero and neonatal exposure to secondhand smoke causes vascular dysfunction in newborn rats. , 1998, Journal of the American College of Cardiology.

[29]  D. Webb,et al.  Impairment of forearm vasodilatation to acetylcholine in hypercholesterolemia is reversed by aspirin. , 1998, Cardiovascular research.

[30]  A. Quyyumi,et al.  Aspirin improves endothelial dysfunction in atherosclerosis. , 1998, Circulation.

[31]  Y. Yazaki,et al.  Angiotensin II type 1a receptor is involved in the occurrence of reperfusion arrhythmias. , 1998, Circulation.

[32]  P. Agostoni,et al.  Comparison of changes in respiratory function and exercise oxygen uptake with losartan versus enalapril in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 1997, The American journal of cardiology.

[33]  M. Verani,et al.  Association of angiotensin I-converting enzyme gene polymorphism with myocardial ischemia and patency of infarct-related artery in patients with acute myocardial infarction. , 1997, Journal of the American College of Cardiology.

[34]  L. Ruilope,et al.  Endothelial dysfunction in spontaneously hypertensive rats: consequences of chronic treatment with losartan or captopril , 1997, Journal of hypertension.

[35]  R. Cartier,et al.  [Effects of chronic administration of captopril on vascular reactivity of the rat aorta]. , 1997, Annales de chirurgie.

[36]  F. Pieruzzi,et al.  Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure. , 1995, Circulation.

[37]  E. J. Brown,et al.  Aspirin enhances the benefits of late reperfusion on infarct shape. A possible mechanism of the beneficial effects of aspirin on survival after acute myocardial infarction. , 1995, Circulation.

[38]  W. Parmley,et al.  Is the reduction of myocardial infarct size by dietary fish oil the result of altered platelet function? , 1994, American heart journal.

[39]  I. Reid,et al.  Role of AT1 receptors in the resetting of the baroreflex control of heart rate by angiotensin II in the rabbit. , 1993, The Journal of clinical investigation.

[40]  W. Parmley,et al.  Aspirin inhibits platelet activity but does not attenuate experimental atherosclerosis. , 1993, American heart journal.

[41]  F. Soubrier,et al.  Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. , 1991, The Journal of biological chemistry.

[42]  L. Keil,et al.  Role of endogenous angiotensin II in the control of vasopressin secretion during hypovolemia and hypotension in conscious rabbits. , 1991, Endocrinology.

[43]  M E Moseley,et al.  A model of acute regional myocardial ischemia and reperfusion in the rat , 1989, Magnetic resonance in medicine.

[44]  W. Linz,et al.  Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts. , 1986, Journal of cardiovascular pharmacology.